Indications:

-Primary Hypercholesterolemia and Mixed Dyslipidemia as adjunctive therapy to diet to
reduce elevated low-density lipoprotein cholesterol (LDL-C), total cholesterol (Total-C), triglycerides (TG), and apolipoprotein B (Apo B), and to increase high-density lipoprotein cholesterol (HDL-C) in adult patients with primary hyperlipidemia or mixed dyslipidemia.
-Hypertriglyceridemia as adjunctive therapy to diet for treatment of adult patients with hypertriglyceridemia.